Ackermans & Van Haaren NV (EBR:ACKB)
Belgium · Delayed Price · Currency is EUR 216.40
-1.60 (-0.73%)
At close: Dec 3, 2025
Ackermans & Van Haaren NV Revenue
Ackermans & Van Haaren NV had revenue of 3.03B EUR in the half year ending June 30, 2025, with 24.94% growth. This brings the company's revenue in the last twelve months to 6.19B, up 9.01% year-over-year. In the year 2024, Ackermans & Van Haaren NV had annual revenue of 6.04B with 15.74% growth.
Revenue (ttm)
6.19B
Revenue Growth
+9.01%
P/S Ratio
1.14
Revenue / Employee
253.90K
Employees
24,384
Market Cap
7.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.04B | 821.78M | 15.74% |
| Dec 31, 2023 | 5.22B | 820.13M | 18.63% |
| Dec 31, 2022 | 4.40B | 104.05M | 2.42% |
| Dec 31, 2021 | 4.30B | 387.12M | 9.90% |
| Dec 31, 2020 | 3.91B | -360.15M | -8.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Umicore | 16.12B |
| Viohalco | 6.78B |
| bpost NV/SA | 4.56B |
| DEME Group NV | 4.30B |
| NV Bekaert | 3.85B |
| Cenergy Holdings | 2.08B |
| Deceuninck NV | 788.98M |
| Floridienne | 719.54M |
Ackermans & Van Haaren NV News
- 12 days ago - Ackermans & Van Haaren Says On Track To Record At Least 15% Annual Earnigns Growth - Nasdaq
- 12 days ago - Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed - GlobeNewsWire
- 2 months ago - Ackermans & van Haaren invests 22 million euros in VKC Nuts - GlobeNewsWire
- 3 months ago - Ackermans & van Haaren supports MRM Health's Series B financing round of 55 million euros - GlobeNewsWire
- 3 months ago - Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners - GlobeNewsWire
- 3 months ago - Ackermans & van Haaren: First-Half 2025 Results - GlobeNewsWire
- 6 months ago - Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority - GlobeNewsWire
- 6 months ago - Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance - GlobeNewsWire